Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Lomecel-B Effects on Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update evaluating Lomecel-B for mild Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: A Relational Research Recruitment and Engagement Intervention for Cognitive Aging Research [NA]
A completed clinical trial evaluating a relational recruitment and engagement intervention for cognitive aging research; results were posted…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) [Phase 3]
Phase 3 trial of gantenerumab in early Alzheimer’s disease was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD) [Phase 3]
Phase 3 trial evaluating long-term safety and tolerability of gantenerumab in Alzheimer's disease has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) [Phase 3]
Phase 3 safety and efficacy study of gantenerumab in early Alzheimer’s disease was terminated with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Enhancing Sleep Quality for Nursing Home Residents With Dementia [NA]
A completed clinical trial focused on improving sleep quality in nursing home residents with dementia and Alzheimer's disease; results poste…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Efficacy, Safety and Response Predictors of Adjuvant Astragalus for Cognition in Orthostatic Hypotension [Phase 2]
Phase 2 clinical trial update evaluating efficacy, safety, and response predictors of adjuvant astragalus for cognition in orthostatic hypot…
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers [NA]
Pilot telehealth program for rural caregivers of individuals with Alzheimer's-related dementia; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Study of BHV-4157 in Alzheimer's Disease [Phase 2]
Phase 2 trial of BHV-4157 in Alzheimer disease completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 trial evaluating daratumumab in patients with mild to moderate Alzheimer's disease has been completed and results have been posted…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Assessing Clinical Outcomes in Alzheimer's Disease Agitation [Phase 3]
Phase 3 clinical trial assessing outcomes in agitation associated with Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: The STEP 4Life Trial [NA]
A completed clinical trial update for the STEP 4Life trial related to Alzheimer disease risk and protection against dementia, with results p…
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: A Phase 3 Study of NE3107 in Probable Alzheimer's Disease [Phase 3]
Phase 3 clinical trial of NE3107 for probable Alzheimer's disease completed.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease [Phase 1, Phase 2]
A clinical trial update for TB006 in Alzheimer's disease spanning Phase 1 and Phase 2, completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type [Phase 3]
A 12-week extension trial evaluated the safety and tolerability of brexpiprazole for agitation associated with Alzheimer's-type dementia (Al…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of Sodium Oligomannate (GV-971) for Alzheimer's disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Enhanced Quality in Primary Care for Elders With Diabetes and Dementia [NA]
A completed clinical trial evaluating enhanced primary care quality for elders with diabetes and dementia, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4) [Phase 3]
A Phase 3 trial (TRAILBLAZER-ALZ 4) comparing donanemab with aducanumab in early symptomatic Alzheimer's disease has completed, with results…
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support [NA]
Completed clinical trial assessing positive emotion regulation and virtual support for reducing caregiver burden in Alzheimer's disease; res…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of T-817MA in patients with mild cognitive impairment related to Alzheimer's disea…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Peripheral Benzodiazepine Receptors (PBR28) Brain PET Imaging With Lipopolysaccharide Challenge for the Study of Microglia Function in Alzheimer's Disease [EARLY_Phase 1]
Early Phase 1 clinical trial evaluating PBR28 PET imaging with LPS challenge to study microglia function in Alzheimer's disease; study compl…
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: Nicotinamide as an Early Alzheimer's Disease Treatment [Phase 2]
Phase 2 trial evaluating nicotinamide as a treatment for Alzheimer's Disease and mild cognitive impairment has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease [Phase 1]
Phase 1 trial update for LY3303560 in mild cognitive impairment or Alzheimer's disease has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL) [Phase 4]
Phase 4 clinical trial updating strategies with cholinesterase inhibitors for Alzheimer disease; status not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2023-09-29Clinical Trial Update: Masitinib in Patients With Mild to Moderate Alzheimer's Disease [Phase 3]
Phase 3 clinical trial update for masitinib in patients with mild to moderate Alzheimer's disease (completed).